Angela Waanders, MD, MPH

Clinical and Community Trials

Biography

  • Interim Head, Neuro-Oncology, Ann & Robert H. Lurie Children’s Hospital of Chicago
  • Director, Precision Medicine Oncology, Ann & Robert H. Lurie Children’s Hospital of Chicago
  • Executive Board Chair, Children's Brain Tumor Tissue Consortium, Ann & Robert H. Lurie Children’s Hospital of Chicago
  • Max Lacewell Endowed Brain Tumor Research Scholar, Ann & Robert H. Lurie Children’s Hospital of Chicago
  • Associate Professor of Pediatrics (Hematology, Oncology, and Stem Cell Transplantation), Northwestern University Feinberg School of Medicine

See Lurie Children's Provider Profile

Education and Background

  • Fellowship in Pediatric Hematology/Oncology, Children's Hospital of Philadelphia 2006-2009
  • Residency is Pediatrics, Children's Hospital of Philadelphia 2003-2006
  • MD, Tulane University School of Medicine 2003

Clinical Studies

Recruiting

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

Recruiting

A Phase II Trial of Poly-ICLC for Low-Grade Gliomas

Recruiting

REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma

Recruiting

A Study to Evaluate DAY101 in Pediatric and Young Adult Patients With Relapsed or Progressive Low-Grade Glioma

Recruiting

Trametinib and Everolimus for the Treatment of Pediatric and Young Adult Patients With Recurrent Low Grade Gliomas (PNOC021)

PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children

Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Recruiting

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Recruiting

Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma

Publications

Feb. 14, 2021

Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1).

Feb. 09, 2021

BRAF fusions in pediatric histiocytic neoplasms define distinct therapeutic responsiveness to RAF paradox breakers.

Feb. 05, 2021

A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study.

See all publications

Similar Researchers

Clinical and Community Trials

Andrew Prigge, MD

Research Interests

Critical Care, Viral Respiratory Infections, Lung Injury and Repair, Immune Regulation

Recent Publication

Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2.

Feb. 01, 2022
Clinical and Community Trials

Brian A. Madden, MD

Research Interests

Interventricular Mechanics, Right Ventricular Failure, Role of Immunologic Phenotype on Post-heart Transplant Outcomes, Post-heart Transplant Kidney Injury and Failure

Clinical and Community Trials

Jeremy N. Wong, MD

Laura E. Vernon, MD

Reega D. Purohit, MD

Alexander J. Kula, MD